Skip to main content
Clinical Trials/NL-OMON37491
NL-OMON37491
Recruiting
Not Applicable

Hereditary breast cancer and the clinical significance of variants in the BRCA1 and BRCA2 genes. - Hereditary breast cancer and DNA Unclassified Variants.

eids Universitair Medisch Centrum0 sites270 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
hereditary breast cancer
Sponsor
eids Universitair Medisch Centrum
Enrollment
270
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) UV\-cohort: patients who are carrier of an unclassified variant.
  • 2\) Affected relatives of the UV\-cohort patients will be invited for this study.
  • 3\) At least one non\-affected family member of the UV\-cohort patients will be invited to take part in this study. ;The UV\-cohort consists of patients diagnosed with a primary breast tumor before the age of 60 years and are unrelated.
  • The patient can be included if only one unclassified variant is found in the BRCA1 or BRCA2 gene.
  • All the participants should be older than 18 years, competent and independent of the researcher.
  • They should all be informed about the study, its goal and its duration.
  • They know about the possibility of interim quitting the study.

Exclusion Criteria

  • \- Younger than 18 years old and older than 60 years old. Not affected family members may however, be older than 60 years old.
  • \-The participants should be competent to be able to make decision about participation.

Outcomes

Primary Outcomes

Not specified

Similar Trials